Ionis Announces Topline Results From Essence Study Of Olezarsen In People With Moderate Hypertriglyceridemia With Or At Risk For Atherosclerotic Cardiovascular Disease; Olezarsen Met Primary Endpoint With A Statistically Significant Mean Reduction In Trig